You have no items in your shopping cart.
On Promotion
Species Host
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Featured Product
Search results for: 'Neurodegenerative Disease'
NSC145366 [orb1737953]1052515-37-3
635.36
C37H63ClN2O4
12 months from date of receipt.
50 mg, 100 mg, 25 mg- NW-1772 free base [orb1737766]
911290-20-5
329.78
C18H16ClNO3
12 months from date of receipt.
50 mg, 100 mg, 25 mg - Ipenoxazone HCl [orb1738182]
118635-68-0
394.98
C22H35ClN2O2
12 months from date of receipt.
50 mg, 100 mg, 25 mg - 4-Hydroxyindole [orb1737447]
97.05% (May vary between batches)
2380-94-1
133.15
C8H7NO
DMSO:Insoluble;H2O:Insoluble
12 months from date of receipt.
1 g, 1 ml - Neurodegenerative Disorder-Targeting Compound 1 [orb1708097]
1254698-39-9
484.55
C28H28N4O4
12 months from date of receipt.
100 mg, 25 mg, 50 mg - Anti-neurodegeneration agent 1 [orb1710570]
289893-23-8
313.78
C14H20ClN3O3
12 months from date of receipt.
50 mg, 100 mg, 25 mg - Aβ42-IN-1 [orb1710515]
2582757-69-3
499
C29H27ClN4O2
12 months from date of receipt.
25 mg, 50 mg, 100 mg - 6RK73 [orb1710529]
99.91% (May vary between batches)
1895050-66-4
307.37
C13H17N5O2S
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (13.01 mM);DMSO:112.5 mg/mL (366.01 mM)
12 months from date of receipt.
1 ml x 10 mM (in DMSO), 10 mg, 50 mg, 500 mg, 1 mg, 5 mg, 25 mg, 100 mg